These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32930624)

  • 1. Apoptosis signal-regulating kinase 1 (ASK1) as a therapeutic target for neurological diseases.
    Takenaka S; Fujisawa T; Ichijo H
    Expert Opin Ther Targets; 2020 Nov; 24(11):1061-1064. PubMed ID: 32930624
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors.
    Fujisawa T
    Adv Biol Regul; 2017 Dec; 66():85-90. PubMed ID: 29066277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.
    Cheon SY; Cho KJ
    J Mol Med (Berl); 2019 Feb; 97(2):153-161. PubMed ID: 30617854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis signal-regulating kinase 1 as a therapeutic target.
    Kawarazaki Y; Ichijo H; Naguro I
    Expert Opin Ther Targets; 2014 Jun; 18(6):651-64. PubMed ID: 24660755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASK1 pharmacophore model derived from diverse classes of inhibitors.
    Starosyla SA; Volynets GP; Bdzhola VG; Golub AG; Protopopov MV; Yarmoluk SM
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4418-4423. PubMed ID: 25172422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and function of apoptosis signal-regulating kinase 1 in rheumatoid arthritis.
    Nygaard G; Di Paolo JA; Hammaker D; Boyle DL; Budas G; Notte GT; Mikaelian I; Barry V; Firestein GS
    Biochem Pharmacol; 2018 May; 151():282-290. PubMed ID: 29408488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease.
    Kefala G; Tziomalos K
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):189-191. PubMed ID: 30791762
    [No Abstract]   [Full Text] [Related]  

  • 8. The redox-active site of thioredoxin is directly involved in apoptosis signal-regulating kinase 1 binding that is modulated by oxidative stress.
    Psenakova K; Hexnerova R; Srb P; Obsilova V; Veverka V; Obsil T
    FEBS J; 2020 Apr; 287(8):1626-1644. PubMed ID: 31623019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and development of ASK1 inhibitors.
    Brys R; Gibson K; Poljak T; Van Der Plas S; Amantini D
    Prog Med Chem; 2020; 59():101-179. PubMed ID: 32362327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.
    Monastyrskyi A; Bayle S; Quereda V; Grant W; Cameron M; Duckett D; Roush W
    Bioorg Med Chem Lett; 2018 Feb; 28(3):400-404. PubMed ID: 29277458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway.
    Kim SY; Kim TJ; Lee KY
    FEBS Lett; 2008 Jun; 582(13):1913-8. PubMed ID: 18501712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors.
    Lovering F; Morgan P; Allais C; Aulabaugh A; Brodfuehrer J; Chang J; Coe J; Ding W; Dowty H; Fleming M; Frisbie R; Guzova J; Hepworth D; Jasti J; Kortum S; Kurumbail R; Mohan S; Papaioannou N; Strohbach JW; Vincent F; Lee K; Zapf CW
    Eur J Med Chem; 2018 Feb; 145():606-621. PubMed ID: 29348070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1.
    Lee JA; Park JE; Lee DH; Park SG; Myung PK; Park BC; Cho S
    Oncogene; 2008 Feb; 27(9):1297-305. PubMed ID: 17700517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation
    Jones JH; Xin Z; Himmelbauer M; Dechantsreiter M; Enyedy I; Hedde J; Fang T; Coomaraswamy J; King KW; Murugan P; Santoro JC; Hesson T; Walther DM; Wei R; Zheng F; Marcotte DJ; Spilker K; Kumar PR; Liu Y; Gilfillan R; Gonzalez-Lopez de Turiso F
    J Med Chem; 2021 Oct; 64(20):15402-15419. PubMed ID: 34653340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects.
    Savira F; Kompa AR; Magaye R; Xiong X; Huang L; Jucker BM; Willette RN; Kelly DJ; Wang BH
    Life Sci; 2021 May; 272():119267. PubMed ID: 33631173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival.
    Eaton GJ; Zhang QS; Diallo C; Matsuzawa A; Ichijo H; Steinbeck MJ; Freeman TA
    Cell Death Dis; 2014 Nov; 5(11):e1522. PubMed ID: 25393478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Insight into the 14-3-3 Protein-dependent Inhibition of Protein Kinase ASK1 (Apoptosis Signal-regulating kinase 1).
    Petrvalska O; Kosek D; Kukacka Z; Tosner Z; Man P; Vecer J; Herman P; Obsilova V; Obsil T
    J Biol Chem; 2016 Sep; 291(39):20753-65. PubMed ID: 27514745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.
    Singh O; Shillings A; Craggs P; Wall I; Rowland P; Skarzynski T; Hobbs CI; Hardwick P; Tanner R; Blunt M; Witty DR; Smith KJ
    Protein Sci; 2013 Aug; 22(8):1071-7. PubMed ID: 23776076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.
    Gibson TS; Johnson B; Fanjul A; Halkowycz P; Dougan DR; Cole D; Swann S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1709-1713. PubMed ID: 28291695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.